Indian stocks: Visit www.stage2stocks.com →

Guardian Pharmacy Services, Inc. Class A

Stage 2 · Advancing · week 5

As of Oct 22, 2026, Guardian Pharmacy Services is in Stage 2, the uptrend phase, now in week 5 (since Sep 22, 2026). It closed at $39.59, 17.5% below its 52-week high and above its 200-day average, which is rising.

Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services to help residents of long-term health care facilities (LTCFs) in the United States. More about the company

$39.59
+1.56% today
$2.5B · Mid cap
Market Neutral — Building

Pro read

Pro

Our read

Early entry: still early enough in its move

Setup score

—

Momentum

Steady

Edge

—

Setup-score rank among Stage 2 peers: #1 of 17 in Medical Care Facilities · #1 of 272 in Health Care

Is GRDN early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…
Stage Cycle Timeline2024-09-26 → 2026-10-22
S? 42w
S2 52w
2024-09-262026-10-22
S1S2S3S4Setup score (0–10, dashed line at 5)
S? 42w → S3 1w → S4 4w → S1 1w → S2 52w → S3 4w → S2 4w current
Total tracked: 108 weeks across 7 stage runs.

GRDN among Medical Care Facilities14th of 49 by relative strength

All 49 →
Stocks in Medical Care Facilities ranked by relative strength, with stage and one-month change
#StockStageRS1M
1AGLStage 3 · wk 898+6.8%
2PACSStage 3 · wk 498+15.7%
3LFSTStage 2 · wk 2497+4.0%
4AMNStage 2 · wk 2596+38.1%
5NHCStage 2 · wk 5995+8.4%
6CONStage 2 · wk 2294+14.9%
7INNVStage 3 · wk 593+5.8%
8MDStage 2 · wk 2692+14.3%
…14GRDNStage 2 · wk 585−8.5%
vs 52W High
-17.5%
$27.03 lo$48.00 hi
17.5% below 52W high, deeper pullback
How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.
Stage Maturity
Week 5
1w13w26w
Week 5, early Stage 2
How long this stock has been in Stage 2. The sweet spot is mid-run: long enough to prove the structure holds, not so long that it's extended. Very fresh moves (weeks 1–4) often need more time to confirm.
vs 200 DMA
4.7%
200 DMA: $37.81 · rising
Long-term trend anchor. When the stock and the S&P 500 are both above their 200-day averages, the backdrop supports continuation.
Rel Volume
0.47x
vs 50-day avg
Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.
Trend Health
↓
Short-term trend rolling over
Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.
1M
-8.5%
3M
-2.1%
6M
+7.1%
YTD
+34.1%
1Y
+46.4%
Scan Membership
Not in any current scan.
Recent Stage Timeline
2026-10-22S2
Wk 5 · Vol 0.47x
2026-10-21S2
Wk 5 · Vol 0.77x
2026-10-20S2
Wk 5 · Vol 1.10x
2026-10-19S2
Wk 4 · Vol 0.69x
2026-10-16S2
Wk 4 · Vol 0.78x
2026-10-15S2
Wk 4 · Vol 0.82x
2026-10-14S2
Wk 4 · Vol 0.73x
2026-10-13S2
Wk 4 · Vol 0.56x
2026-10-12S2
Wk 3 · Vol 1.38x
2026-10-09S2
Wk 3 · Vol 0.75x
2026-10-08S2
Wk 3 · Vol 1.10x
2026-10-07S2
Wk 3 · Vol 0.75x
Moving averages & range
50 DMA
$40.83
200 DMA
$37.81
52W High
$48.00
52W Low
$27.03
5D Low
$38.98
Resistance levels (recent highs)
20d High
$42.38
60d High
$48.00
120d High
$48.00
250d High
$48.00
Next resistance
+7.0%
to 20d High
P/E (TTM)
38.4
Forward 27.6
Earnings Growth (YoY)
+139.8%
Revenue +2.2%
ROE
+30.4%
Profit margin +4.5%
Dividend Yield
0.00%
P/B 10.2

Guardian Pharmacy Services: quick answers

What stage is Guardian Pharmacy Services in?

As of Oct 22, 2026, Guardian Pharmacy Services (GRDN) is in Stage 2, the uptrend phase. It entered Stage 2 on Sep 22, 2026 and is in week 5. What the four stages mean

Is Guardian Pharmacy Services in an uptrend?

Yes. Guardian Pharmacy Services is in a Stage 2 uptrend. It trades 4.7% above its 200-day average, which is rising.

How far is Guardian Pharmacy Services from its 52-week high?

Guardian Pharmacy Services closed at $39.59 on Oct 22, 2026, 17.5% below its 52-week high of $48.00. Its 52-week low is $27.03.

How has Guardian Pharmacy Services performed over the past year?

As of Oct 22, 2026, Guardian Pharmacy Services is up 46.4% over the past year and up 34.1% so far in 2026.

Which sector and industry is Guardian Pharmacy Services in?

Guardian Pharmacy Services is in the Medical Care Facilities industry, part of the Health Care sector.

About this companyHealth Care· Medical Care Facilities

Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services to help residents of long-term health care facilities (LTCFs) in the United States. The company's individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities, behavioral health facilities, and group homes. Its Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; GuardianShield Programs for LTCFs; Order Entry QA Analyzer, which utilizes real-time rules- engine technology to examine prescriptions and detect omissions and/or errors before they become a customer service problem; and Medication Spend Analyzer to break down the monthly drug spending for each of the LTCFs. Guardian Pharmacy Services, Inc. was founded in 2003 and is headquartered in Atlanta, Georgia.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.